Dyne Therapeutics to present DMD preclinical data at NMSG meeting
Dyne Therapeutics, Inc. (Nasdaq: DYN) plans to present preclinical data for four investigational therapies for Duchenne muscular dystrophy (DMD) at ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)